ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,714.75
      -0.25%
      US Tech 100
      19,474.80
      -0.11%
      Dow Jones
      41,795.87
      -0.61%
      Brent Oil
      75.175
      1.48%
      Bitcoin
      67,562.82
      -1.71%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Elevai Labs Inc (ELAB) Quote

      Elevai Labs Inc

      Elevai Labs Inc (ELAB)

      NASDAQ
      0.02
      -0.0089
      ( -30.80% )
      Updated: 15:18:58
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.02
      Bid
      0.0199
      Ask
      0.02
      Volume
      237,197,919
      0.019 Day's Range 0.0244
      0.019 52 Week Range 4.2442
      Market Cap
      403.842k
      Previous Close
      0.0289
      Open
      0.0234
      Last Trade
      29
      @
      0.020066
      Last Trade Time
      15:19:04
      Financial Volume
      $ 4,985,284
      VWAP
      0.021017
      Average Volume (3m)
      29,611,527
      Shares Outstanding
      20,192,114
      Dividend Yield
      -
      PE Ratio
      -0.09
      Earnings Per Share (EPS)
      -0.21
      Revenue
      1.71M
      Net Profit
      -4.3M

      About Elevai Labs Inc

      Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed... Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      elevailabs.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Elevai Labs Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ELAB. The last closing price for Elevai Labs was $0.03. Over the last year, Elevai Labs shares have traded in a share price range of $ 0.019 to $ 4.2442.

      Elevai Labs currently has 20,192,114 shares outstanding. The market capitalization of Elevai Labs is $583,552.09 . Elevai Labs has a price to earnings ratio (PE ratio) of -0.09.

      Ask ADVFN Intelligence (AI)

      ELAB Latest News

      More News

      FeaturedNorth Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia

      7 hours ago

      Form 8-K - Current report

      October 31 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      October 25 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      October 24 2024
      Edgar (US Regulatory)

      Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity

      NEWPORT BEACH, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- EL-22 is a novel myostatin asset for the potential treatment of obesity in combination with existing GLP-1 medicinesThe Investigational...

      October 22 2024
      GlobeNewswire Inc.

      Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity

      Preclinical results of EL-32 demonstrated statistically significant increases in grip strength, motor function and body composition in aged C57BL/6J mouse model.Elevai believes that EL-32 has the...

      October 21 2024
      GlobeNewswire Inc.

      Form DEF 14C - Other definitive information statements

      October 09 2024
      Edgar (US Regulatory)

      Form SC TO-I - Tender offer statement by Issuer

      October 04 2024
      Edgar (US Regulatory)

      Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock

      NEWPORT BEACH, Calif., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Elevai Labs, Inc. (NASDAQ: ELAB) ("Elevai" or the "Company"), a leader in medical aesthetics, today announced the commencement of an...

      October 04 2024
      GlobeNewswire Inc.

      REPEAT: Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations

      Filed two patent applications for lead candidate EL-22, covering muscle loss in obese patients as a monotherapy and in combination with GLP-1 receptor agonistsElevai Biosciences patent portfolio...

      October 03 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.0739-78.70074547390.09390.1050.019606595620.04564347CS
      4-0.0895-81.73515981740.10950.1840.019448181470.08190605CS
      12-0.3243-94.1911124020.34430.390.019296115270.11670712CS
      26-0.67-97.10144927540.690.70.019140176900.11805039CS
      52-3.98-99.544.24420.01978100180.17875199CS
      156-3.98-99.544.24420.01978100180.17875199CS
      260-3.98-99.544.24420.01978100180.17875199CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      SPPLSIMPPLE Ltd
      $ 1.23
      (284.38%)
      		360.4M
      NUWENewellis Inc
      $ 2.8301
      (108.10%)
      		97.15M
      STAFStaffing 360 Solutions Inc
      $ 2.8697
      (68.81%)
      		50.18M
      ADNAdvent Technologies Holdings Inc
      $ 3.1001
      (63.16%)
      		61.69M
      OMICSingular Genomics Systems Inc
      $ 21.55
      (60.10%)
      		295.44k
      TOIIWOncology Institute Inc
      $ 0.0101
      (-47.67%)
      		58.22k
      SSPEW Scripps Company
      $ 2.215
      (-37.07%)
      		3.81M
      INVZWInnoviz Technologies Ltd
      $ 0.0642
      (-33.13%)
      		1.02k
      GCTKGlucoTrack Inc
      $ 1.17
      (-32.76%)
      		76.75k
      ILLRTriller Group Inc
      $ 2.9185
      (-31.81%)
      		2.11M
      SPPLSIMPPLE Ltd
      $ 1.22
      (281.25%)
      		360.4M
      ELABElevai Labs Inc
      $ 0.02015
      (-30.28%)
      		235.47M
      SQQQProShares UltraPro Short QQQ
      $ 7.485
      (0.60%)
      		145.64M
      NVDANVIDIA Corporation
      $ 137.5534
      (1.59%)
      		144.09M
      DJTTrump Media and Technology Group Corporation
      $ 33.6682
      (10.17%)
      		101.63M

      ELAB Discussion

      View Posts
      pinkslipjunkie pinkslipjunkie 37 minutes ago
      Most stocks that drop under .1 for the first time will usually bounce back above .1 at least once but they usually don't drop this much in such a sharp decline...all I can say is when this what looks like dilution stops we should at least see a bounce to .06 again, even though .1 could be feasible
      👍️0
      Shawonsarker84 Shawonsarker84 2 hours ago
      5 days RSI 14! Way oversold
      👍️0
      Money hunt Money hunt 2 hours ago
      Double bottom explosion
      👍️0
      Money hunt Money hunt 2 hours ago
      Hold on to your shares, Load and hold dudes!! we going green
      👍️0
      RAlbert RAlbert 3 hours ago
      It cannot continue the downfall like a water fall. Last 4 sessions it is the same. Must be something that seriously damaging our investment
      👍️0
      Money hunt Money hunt 8 hours ago
      Put on your sunglasses blue skies up ahead
      👍️0
      RAlbert RAlbert 8 hours ago
      It would be last day to get cheap shares. Very low outstanding shares high volumes could anytime be a 10cent stock
      👍️0
      Money hunt Money hunt 22 hours ago
      Got to get the sour lemons out of here
      👍️0
      Money hunt Money hunt 22 hours ago
      The reward is worth the risk, I don’t really care what anyone says. If I lose I lose, but if I win, it’ll be very profitable.
      👍️0
      MetaMonster MetaMonster 1 day ago
      Sharks smell blood, pharma whales coming for the kill
      👍️0
      MetaMonster MetaMonster 1 day ago
      Retail Squads WSB and Discord MoonShots.... Get ready for .20+ Tomorrow
      👍️0
      MetaMonster MetaMonster 1 day ago
      Lmao , EPIC SQUEEZE and a Brand New Meme Stock Frenzy to watch the short rat scumbag bastards rot in hell where they belong forever
      👍️0
      Money hunt Money hunt 2 days ago
      50M shares outstanding @ .30 would take it to a 15m market cap that’s a start
      👍️0
      MartinLutherKing MartinLutherKing 2 days ago
      Hail Breakthrough to all fatzoos!!
      👍️0
      MartinLutherKing MartinLutherKing 2 days ago
      We the next DRUG Move on up to the mountain top news
      👍️0
      MetaMonster MetaMonster 2 days ago
      10 Bag to 30 cents would be a fair evaluation
      👍️0
      MetaMonster MetaMonster 2 days ago
      Shorts are burnt toast
      Shares Outstanding
      49.38M
      Public Float
      16.58M
      $1.43M Market cap
      👍️0
      MetaMonster MetaMonster 2 days ago
      It's a collapse, all positive news with a huge shake out, Explosive move next
      👍️0
      MetaMonster MetaMonster 2 days ago
      Dirty rat bastard scumbags shorts will burn in hell next week... Stay tuned ...
      👍️0
      MartinLutherKing MartinLutherKing 2 days ago
      .10+ Incoming brothers
      👍️0
      MartinLutherKing MartinLutherKing 3 days ago
      Monster news monday morning will rattle ELAB
      👍️0
      MartinLutherKing MartinLutherKing 3 days ago
      Going to grab this bull by the horns brother
      👍️0
      MartinLutherKing MartinLutherKing 3 days ago
      Is that all you got shorties?? Bring it on
      👍️0
      MartinLutherKing MartinLutherKing 3 days ago
      Time to move on up to the next level
      👍️0
      MartinLutherKing MartinLutherKing 3 days ago
      Grab all you can now brother
      👍️0
      RAlbert RAlbert 3 days ago
      Slid it buy at these level or wait ?
      👍️0
      pinkslipjunkie pinkslipjunkie 3 days ago
      Fuuuu..they are beating the shit out of this with those ask blocks
      👍️0
      MartinLutherKing MartinLutherKing 3 days ago
      Load and hold for lift-off
      👍️0
      MartinLutherKing MartinLutherKing 3 days ago
      Power hour fun
      👍️0
      RAlbert RAlbert 3 days ago
      I am in the party too 😍
      👍️0
      MartinLutherKing MartinLutherKing 3 days ago
      Shake Shake rattle and roll brother
      👍️0
      pinkslipjunkie pinkslipjunkie 3 days ago
      The Investigational New Drug application is planned for submission to the U.S. Food and Drug Administration (“FDA”) in 2025
      👍️0
      MartinLutherKing MartinLutherKing 3 days ago
      Let’s do this brother, EL-22 For The Treatment of Obesity
      👍️0
      MartinLutherKing MartinLutherKing 3 days ago
      Let’s all hold hands to glory Food and Drug Administration For EL-22 approval for The Treatment of Obesity
      👍️0
      pinkslipjunkie pinkslipjunkie 3 days ago
      I'm squeezing...I'm squeezing!
      👍️0
      MartinLutherKing MartinLutherKing 3 days ago
      Now let’s squeeze together brother
      👍️0
      MartinLutherKing MartinLutherKing 3 days ago
      Super squeeze real deal hollyfield right here brother, stay tuned for lift off..
      👍️0
      pinkslipjunkie pinkslipjunkie 3 days ago
      They must because this thing has been bleeding bad...time to heal the wound.
      👍️0
      MartinLutherKing MartinLutherKing 3 days ago
      EL-22 For The Treatment of Obesity blockbuster for all fatzos out there
      👍️0
      MartinLutherKing MartinLutherKing 3 days ago
      Pharma whales smell blood
      Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity
      👍️0
      pinkslipjunkie pinkslipjunkie 3 days ago
      LOL...funny way to put it...works for me.
      👍️0
      MartinLutherKing MartinLutherKing 3 days ago
      Same here brother to the mountain top with Fda fast track status
      👍️0
      pinkslipjunkie pinkslipjunkie 3 days ago
      I hope so Mister King I just tripled my position now with an entry of .0365
      👍️0
      MartinLutherKing MartinLutherKing 3 days ago
      moass brothers
      👍️0
      MartinLutherKing MartinLutherKing 3 days ago
      Open up the flood gates your about to witness monster volume short squeeze
      👍️0
      Money hunt Money hunt 5 days ago
      The dip is inn dudes!!!
      👍️0
      Money hunt Money hunt 5 days ago
      The roof is on fire dudes!!!🚀🚀🚀🚀
      👍️0
      MetaMonster MetaMonster 5 days ago
      Short scumbag rat bastards will all end up in hell
      👍️0
      Money hunt Money hunt 5 days ago
      Or will it collapse!!
      👍️0
      Money hunt Money hunt 5 days ago
      Will it help hit 1$ dude!!!
      👍️0

      Your Recent History

      NASDAQ
      ELAB
      Elevai Labs
      NASDAQ
      BSLK
      Bolt Projects
      LSE
      0R0X
      Tesla
      AQSE
      COIN
      Coinsilium
      TG
      APC6
      Apple
      BITMOT
      781860
      Austria Tf 3,8% Ge62 Eur
      NASDAQI
      CIX100
      Cryptoindex com
      BOV
      L1EN34
      Lennar
      FX
      PENUSD
      PEN vs US Dollar
      LSE
      CTP
      Castleton Technology
      BSTP
      GODSEUR
      Gods Unchained
      NASDAQ
      RBNC
      Reliant Bancorp
      COIN
      CUBTUSD
      CubToken
      Delayed Upgrade Clock